FDA extends deadline for e-prescribing comments
Dec. 6 is new deadline for public comments regarding electronic distribution of prescribing information for Rx drugs.
Apparently not satisfied with the volume of comments it has received, the FDA has extended the comment period regarding electronic distribution of prescribing information for prescription drug products. The new deadline for comments, as published in the Oct. 22
Recent Videos
Related Content
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023Article
A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
